NASDAQ:ODTX Odyssey Therapeutics Q1 2026 Earnings Report $23.64 -0.87 (-3.55%) As of 09/10/2026 04:00 PM Eastern ProfileEarnings HistoryForecast Odyssey Therapeutics EPS ResultsActual EPS-$6.77Consensus EPS -$1.31Beat/MissMissed by -$5.46One Year Ago EPSN/AOdyssey Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AOdyssey Therapeutics Announcement DetailsQuarterQ1 2026Date6/17/2026TimeAfter Market ClosesConference Call DateWednesday, June 17, 2026Conference Call Time8:00AM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Odyssey Therapeutics Earnings HeadlinesWhat is HC Wainwright's Estimate for ODTX Q3 Earnings?August 31, 2026 | americanbankingnews.comOdyssey Therapeutics to Participate in Upcoming Investor ConferencesAugust 26, 2026 | globenewswire.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | Investors Alley (Ad)Odyssey Therapeutics Inc.August 18, 2026 | marketwatch.comOdyssey Therapeutics: Q2 Earnings SnapshotAugust 6, 2026 | chron.comEvotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory DiseasesAugust 6, 2026 | prnewswire.comSee More Odyssey Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Odyssey Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Odyssey Therapeutics and other key companies, straight to your email. Email Address About Odyssey TherapeuticsOdyssey Therapeutics (NASDAQ:ODTX) Inc. is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines which are designed to precisely target disease pathology. Odyssey Therapeutics Inc. is based in BOSTON.View Odyssey Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles AeroVironment's Record Backlog and Earnings Beat Fuel Recovery CaseGameStop’s Comeback Case Is Getting Interesting, But eBay Still Looks StrongerChewy’s Sell-Off Puts Its Recurring Revenue Story Back on Trial for InvestorsWhy Braze’s Guidance Miss May Be a Gift for InvestorsCasey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality RetailerCathie Wood Trimmed Palantir, But the Bigger Story Is Still ValuationVictoria’s Secret’s Comeback Is Real—The Stock’s Problem Is Different Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
